Treatment of pneumonia and its implications for antimicrobial resistance: Introduction

Chest

Volumn 115, Issue 3 SUPPL., 1999, Pages 1S-2S

  Bernstein, J M ^a   Campbell G D , Jr ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL OVERGROWTH; DRUG CHOICE; EDITORIAL; ENTEROCOCCUS; HOSPITAL INFECTION; HUMAN; INFECTIOUS PNEUMONIA; INTENSIVE CARE UNIT; PHARMACODYNAMICS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 0033047102     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (2)

1. HM Foy MK Cooney I Allan Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975 JAMA 241 1979 253 258
2. American Thoracic Society Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy Am Rev Respir Dis 148 1993 1418 1426